PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.29
Similar ESG score to ADAP's 62.74. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
50.00
Similar environmental score to ADAP's 50.00. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
62.54
Social score below 80% of ADAP's 78.41. Jim Chanos would check for potential social license and litigation risks.
68.32
Governance score 1.1-1.2x ADAP's 59.80. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.